Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

A microarray study of altered gene expression after cytarabine resistance in acute myeloid leukemia

A Retraction to this article was published on 11 August 2010

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Galmarini CM, Thomas X, Calvo F, Rousselot P, Rabilloud M, El Jaffari A et al. In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. Br J Haematol 2002; 117: 860–868.

    Article  CAS  PubMed  Google Scholar 

  2. Largaespada DA, Shaughnessy Jr JD, Jenkins NA, Copeland NG . Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. J Virol 1995; 69: 5095–5102.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Yin B, Kogan SC, Dickins RA, Lowe SW, Largaespada DA . Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia. Exp Hematol 2006; 34: 631–641.

    Article  CAS  PubMed  Google Scholar 

  4. Le Beau MM, Bitts S, Davis EM, Kogan SC . Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. Blood 2002; 99: 2985–2991.

    Article  CAS  PubMed  Google Scholar 

  5. Baldus CD, Liyanarachchi S, Mrozek K, Auer H, Tanner SM, Guimond M et al. Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: amplification discloses overexpression of APP, ETS2, and ERG genes. Proc Natl Acad Sci USA 2004; 101: 3915–3920.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605–1616.

    Article  CAS  PubMed  Google Scholar 

  7. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617–1628.

    Article  CAS  PubMed  Google Scholar 

  8. Zhou Y, Xu Y, Tan Y, Qi J, Xiao Y, Yang C et al. Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk Res 2006; 30: 469–476.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge support from the Leukemia and Lymphoma Society of America (LLS 7019-04, Specialized Center of Research).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D A Largaespada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yin, B., Tsai, M., Hasz, D. et al. A microarray study of altered gene expression after cytarabine resistance in acute myeloid leukemia. Leukemia 21, 1093–1097 (2007). https://doi.org/10.1038/sj.leu.2404595

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.leu.2404595

This article is cited by

Search

Quick links